Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005.

Epidemiology of rare cutaneous malignancies in the general population is poorly documented. This descriptive study aimed to estimate the incidence and trends of all skin malignancies between 1989 and 2005. Data on skin tumors were extracted from the Netherlands Cancer registry (except for basal cell carcinoma (BCC) data-only available from Comprehensive Cancer Centre South) and categorized according to the International Classification of Diseases for Oncology, third edition, codes. Age-standardized incidence rates (European standardized population rate, ESR) per 100,000 person-years were calculated per year and for the period between 2001 and 2005. Estimated annual percentage changes (EAPCs) were estimated by Poisson regression models. A total of 356,620 skin tumors were diagnosed between 1989 and 2005. Excluding BCC, squamous cell carcinoma (SCC), and melanoma, the remaining skin tumors constituted about 2% of all skin malignancies. The incidence of melanoma showed the steepest increase (EAPC, 4.0%), and ESR was close to that observed for SCC (EAPC, 2.3%) between 2001 and 2005 (17.1 versus 19.6). Hematolymphoid tumors (ESR=0.74) were mainly cutaneous T-cell lymphomas (60.8%). No significant increases in incidence were observed for lymphomas, and appendageal, fibromatous, and myomatous carcinomas during 1989-2005. In addition to keratinocytic cancers and melanoma, there is a wide variety of skin tumors that constitute <2% of all skin malignancies. The incidence of UV-related skin tumors increased significantly and more steeply than did those of other skin malignancies.

[1]  David Koh,et al.  Skin cancer trends among Asians living in Singapore from 1968 to 2006. , 2009, Journal of the American Academy of Dermatology.

[2]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[3]  A. Katalinic,et al.  Epidemiology of cutaneous melanoma and non‐melanoma skin cancer in Schleswig‐Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer) , 2003, The British journal of dermatology.

[4]  M. Weinstock,et al.  Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. , 1988, JAMA.

[5]  A. Hannuksela-Svahn,et al.  Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. , 1999, Archives of dermatology.

[6]  S. Devesa,et al.  Cutaneous soft tissue sarcoma incidence patterns in the U.S. , 2008, Cancer.

[7]  M. M. Morales Suarez-Varela,et al.  Mycosis fungoides: Review of Epidemiological Observations , 2000, Dermatology.

[8]  A. Eggermont,et al.  Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? , 2003, European journal of cancer.

[9]  D. Brewster,et al.  Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003 , 2007, The British journal of dermatology.

[10]  M. Weinstock,et al.  Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. , 2007, Journal of the American Academy of Dermatology.

[11]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[12]  Nicole C Hodgson,et al.  Merkel cell carcinoma: Changing incidence trends , 2005, Journal of surgical oncology.

[13]  A. Gavin,et al.  Skin cancer trends in Northern Ireland and consequences for provision of dermatology services , 2007, The British journal of dermatology.

[14]  Tamar Nijsten,et al.  [Skin cancer epidemic in the Netherlands]. , 2009, Nederlands tijdschrift voor geneeskunde.

[15]  C. Vachon,et al.  Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. , 2005, JAMA.

[16]  R. Stern.  The mysteries of geographic variability in nonmelanoma skin cancer incidence. , 1999, Archives of dermatology.

[17]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[18]  Harry Harmens,et al.  Working group report , 2011 .

[19]  S. Devesa,et al.  Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases , 2006, International journal of cancer.

[20]  D. Greenberg,et al.  Melanoma epidemic: a midsummer night’s dream? , 2009, The British journal of dermatology.

[21]  L. Wilson,et al.  A retrospective review of 1349 cases of sebaceous carcinoma , 2009, Cancer.

[22]  M. Cristofolini,et al.  Epidemiology of Skin Tumors: Data from the Cutaneous Cancer Registry in Trentino, Italy , 2003, Journal of cutaneous medicine and surgery.

[23]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[24]  D. Weisenburger,et al.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.

[25]  J. Boldrick,et al.  Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. , 2005, The Journal of investigative dermatology.

[26]  J. Fraumeni,et al.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms , 2008, Cancer.

[27]  I. Matalka,et al.  Skin cancer trends in northern Jordan , 2006, International journal of dermatology.

[28]  S. Devesa,et al.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. , 2009, Blood.